The kidney and bisphosphonates
- 31 July 2011
- journal article
- review article
- Published by Elsevier BV in Bone
- Vol. 49 (1), 77-81
- https://doi.org/10.1016/j.bone.2010.12.024
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisThe New England Journal of Medicine, 2009
- The Pathogenesis of Vascular Calcification in the Chronic Kidney Disease Mineral Bone Disorder: The Links Between Bone and the VasculatureSeminars in Nephrology, 2009
- The Role of Bone Biopsy in Patients with Chronic Renal FailureClinical Journal of the American Society of Nephrology, 2008
- Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal womenKidney International, 2008
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureThe New England Journal of Medicine, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisThe New England Journal of Medicine, 2007
- Safety and Efficacy of Risedronate in Patients With Age-Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical TrialsJournal of Bone and Mineral Research, 2005
- Dose‐Proportional Pharmacokinetics of Risedronate on Single‐Dose Oral Administration to Healthy VolunteersThe Journal of Clinical Pharmacology, 2000
- Adverse Effects of BisphosphonatesDrug Safety, 1996
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976